Sign in

CIK 0001653087 · Accelerated filer<br>Smaller reporting company

Alector, Inc.

Sign in to watch
Ticker
ALEC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
822933343
Phone
415-231-5660
Business address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
Former names
Alector LLC
  1. 144 Insider Sale of Securities
  2. 4 Gift Chief Executive Officer gave 1,050,000 shares (gift)
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. 4 Grant or award Principal Accounting Officer acquired 20,000 shares (grant or award)
  6. 8-K Event Agreement ended
  7. 4 Grant or award Director acquired 28,700 shares (grant or award)
  8. 4 Grant or award Director acquired 28,700 shares (grant or award)
  9. 4 Grant or award Director acquired 28,700 shares (grant or award)
  10. 8-K Event Shareholder vote results
  11. 4 Grant or award Director acquired 28,700 shares (grant or award)
  12. 4 Grant or award Director acquired 28,700 shares (grant or award)
  13. 4 Grant or award Director acquired 28,700 shares (grant or award)
  14. 4 Grant or award Director acquired 28,700 shares (grant or award)
  15. 4 Grant or award Director acquired 10,833 shares (grant or award)
  16. 4 Open-market sale Chief Executive Officer sold 87,216 shares at $1.97 ($172,191)
  17. 4 Open-market sale Principal Accounting Officer sold 9,184 shares at an average $1.94 ($17,813)
  18. 4 Open-market sale CFO & Chief Business Officer sold 19,360 shares at $1.97 ($38,221)
  19. 144 Insider Sale of Securities
  20. 144 Insider Sale of Securities

Page 2 of 32 · 631 filings